Administrative Core for a Center that advances precision medicine using liquid biopsy tools
Official title: Administrative Core
Funded at University of Kansas Lawrence · NIH-11336089 · Data updated 2026-11-12
This NIH grant funds an Administrative Core to support a center that develops and refines liquid biopsy technologies to guide personalized care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Lawrence NIH-funded |
| Lab location | 1 site (Lawrence, United States) |
| Project start | September 16, 2015 |
| Project end | March 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $568,652 |
| NIH project number | 2P41EB020594-12 |
| Project ID | NIH-11336089 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with diseases where liquid biopsy markers are informative (e.g., cancer and other conditions where circulating biomarkers are relevant) could benefit from eventual clinical translation.
✕Less likely to help
Patients not yet suitable for liquid biopsy-guided decisions or whose conditions lack circulating biomarkers may not directly benefit.
What this research studies
The Administrative Core supports a multi-institution center focused on precision medicine by coordinating research activities, governance, and reporting. It highlights new modular, automated fluidic platforms and non-amplified molecular analyses of circulating markers such as cells, cell-free DNA, extracellular vesicles, and their cargos. The core will help enable collaborations, track annual progress, and manage committee oversight to accelerate clinical applications. This is about building and coordinating leading-edge tools that could someday inform treatment decisions for people with various diseases.
Why it matters
Potential benefit: If successful, it could streamline access to advanced liquid biopsy tools that inform personalized treatment decisions.
How similar studies have gone: Similar liquid biopsy platforms have shown promise in guiding clinical decisions, with ongoing improvement and regulatory progression for some implementations.
Where this research is happening
-
University of Kansas Lawrence
Lawrence, United States Active
Researchers
- Principal investigator: Soper, Steven Allan — University of Kansas Lawrence
- Study coordinator: Soper, Steven Allan
Related research
Other NIH-funded projects on the same topics.
-
KC Youth Violence Prevention Center: A comprehensive plan to reduce youth violence
A program in Kansas City aims to reduce youth violence and deaths by applying a coordinated, community-focused approach.
-
Gene regulation and the genetic basis of complex traits (how our genes influence survival and trait differences)
Researchers are studying how genetic differences that affect gene regulation contribute to when and how people survive and reproduce, especially in natural populations.
-
Finding new treatments and understanding how congenital glycosylation disorders work
A research project aims to uncover how certain congenital glycosylation disorders develop and identify existing drugs that could help treat DPAGT1-CDG.
-
How ADP-ribosylation controls our antiviral defenses
Researchers are studying a cellular modification called ADP-ribosylation and how it helps the body fight viruses, with a focus on how coronaviruses interact with this process.
-
Chemoenzymatic synthesis to make biologically active molecules using enzyme libraries
A scientist team will develop enzyme-based methods to make complex drug-like molecules that could help fight cancer and other diseases.
-
DNA breaks and repair in opioid addiction
This project looks at how DNA damage and repair in brain cells may influence opioid addiction and relapse in people and animal models.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.